Adalimumab | Golimumab | |
N=96 | N=87 | |
Colectomy-free survival data | ||
Missing, n | 0 | 1 |
Events, n | 8 | 6 |
Censored, n | 88 | 80 |
Time from treatment initiation (months) | Patients remaining colectomy free, (%) | |
3 | 99.0 | 97.7 |
6 | 95.8 | 96.5 |
9 | 94.8 | 94.2 |
12 | 91.7 | 94.2 |
Time (months) | ||
95% of patients remaining colectomy free | 6.1 | 8.5 |